Guidance for Fulgent Genetics, Inc. (FLGT)
| Period | Range | Estimate | Revenue Range | Revenue Estimate | Target | Details |
|---|---|---|---|---|---|---|
| 2025 | $0.30 | ($0.35) | $325.00M | $320.10M | = Maintained | Details |
| 2025 | ($0.35) | ($0.55) | $320.00M | $310.70M | = Maintained | Details |
| 2025 | ($0.65) | ($0.66) | $310.00M | $310.40M | = Maintained | Details |
| 2025 | ($0.65) | ($0.37) | $310.00M | $324.00M | = Maintained | Details |
| 2024 | N/A | N/A | $280.00M | $282.20M | = Maintained | Details |
| 2024 | ($0.30) | ($0.92) | $280.00M | $280.00M | = Maintained | Details |
| 2024 | ($1.05) | ($1.06) | $280.00M | $279.40M | = Maintained | Details |
| 2024 | ($1.05) | ($0.95) | $280.00M | $294.20M | = Maintained | Details |
| 2023 | ($0.95) | ($0.95) | $260.00M | $265.20M | = Maintained | Details |
| 2022 | $6.00 | $6.23 | $665.00M | $649.60M | = Maintained | Details |
| 2022 | $6.00 | $7.00 | $660.00M | $650.00M | = Maintained | Details |
| 2022 | N/A | N/A | $600.00M | $587.87M | = Maintained | Details |
| Q3 2022 | N/A | N/A | $105.00M | $106.30M | = Maintained | Details |
| Q1 2022 | N/A | N/A | $245.00M | $197.55M | = Maintained | Details |
| 2021 | N/A | N/A | $930.00M | $948.00M | = Maintained | Details |
| 2021 | $12.50 | $12.57 | $800.00M | $829.00M | = Maintained | Details |
| 2021 | $12.50 | $12.27 | $830.00M – 800.00M | $789.40M |  Raised |
Details |
| 2021 | $12.50 | $11.55 | $800.00M | $600.24M | Raised |
Details |
| Q1 2017 | N/A | N/A | N/A | N/A | = Maintained | Details |
